These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1946 related articles for article (PubMed ID: 33513419)
21. [Mechanism of Dabugan Decoction in treatment of generalized anxiety disorder based on network pharmacology and experimental verification]. Li YM; Ma XL; Huang SQ; Wei CX; Tan GW; An YR; Wang XR Zhongguo Zhong Yao Za Zhi; 2024 Jun; 49(12):3373-3384. PubMed ID: 39041101 [TBL] [Abstract][Full Text] [Related]
22. Network pharmacology-based prediction and verification of the active ingredients and potential targets of Huagan Decoction for reflux esophagitis. Zhao Y; Cao Y; Yang X; Guo M; Wang C; Zhang Z; Zhang Q; Huang X; Sun M; Xi C; Tangthianchaichana J; Bai J; Du S; Lu Y J Ethnopharmacol; 2022 Nov; 298():115629. PubMed ID: 35988839 [TBL] [Abstract][Full Text] [Related]
23. Investigating the active compounds and mechanism of HuaShi XuanFei formula for prevention and treatment of COVID-19 based on network pharmacology and molecular docking analysis. Wang J; Ge W; Peng X; Yuan L; He S; Fu X Mol Divers; 2022 Apr; 26(2):1175-1190. PubMed ID: 34105049 [TBL] [Abstract][Full Text] [Related]
24. [Effect of Maxing Shigan Decoction and dissembled prescriptions against airway inflammation in RSV-aggravated asthma and mechanism of regulating TRPV1]. Li MW; Fan XS; Zhou LP; Liu M; Shang EX Zhongguo Zhong Yao Za Zhi; 2022 Nov; 47(21):5872-5881. PubMed ID: 36472006 [TBL] [Abstract][Full Text] [Related]
25. Integrated network pharmacology analysis and in vitro validation revealed the underlying mechanism of Xiyanping injection in treating coronavirus disease 2019. Li J; Guo S; Tan Y; Zhang J; Wu Z; Stalin A; Zhang F; Huang Z; Wu C; Liu X; Huang J; Wu J Medicine (Baltimore); 2023 Aug; 102(34):e34866. PubMed ID: 37653800 [TBL] [Abstract][Full Text] [Related]
26. Exploring the immune-inflammatory mechanism of Maxing Shigan Decoction in treating influenza virus A-induced pneumonia based on an integrated strategy of single-cell transcriptomics and systems biology. Zhang S; Li B; Zeng L; Yang K; Jiang J; Lu F; Li L; Li W Eur J Med Res; 2024 Apr; 29(1):234. PubMed ID: 38622728 [TBL] [Abstract][Full Text] [Related]
27. Investigation of the Active Ingredients and Mechanism of Hudi Enteric-Coated Capsules in DSS-Induced Ulcerative Colitis Mice Based on Network Pharmacology and Experimental Verification. Ding P; Liu J; Li Q; Lu Q; Li J; Shi R; Shi L; Mao T; Ge D; Niu H; Peng G; Wang Z Drug Des Devel Ther; 2021; 15():4259-4273. PubMed ID: 34675488 [TBL] [Abstract][Full Text] [Related]
28. Network pharmacology analysis of the therapeutic mechanisms of the traditional Chinese herbal formula Lian Hua Qing Wen in Corona virus disease 2019 (COVID-19), gives fundamental support to the clinical use of LHQW. Zheng S; Baak JP; Li S; Xiao W; Ren H; Yang H; Gan Y; Wen C Phytomedicine; 2020 Dec; 79():153336. PubMed ID: 32949888 [TBL] [Abstract][Full Text] [Related]
29. Identification of FDA approved drugs against SARS-CoV-2 RNA dependent RNA polymerase (RdRp) and 3-chymotrypsin-like protease (3CLpro), drug repurposing approach. Molavi Z; Razi S; Mirmotalebisohi SA; Adibi A; Sameni M; Karami F; Niazi V; Niknam Z; Aliashrafi M; Taheri M; Ghafouri-Fard S; Jeibouei S; Mahdian S; Zali H; Ranjbar MM; Yazdani M Biomed Pharmacother; 2021 Jun; 138():111544. PubMed ID: 34311539 [TBL] [Abstract][Full Text] [Related]
30. Identifying potential treatments of COVID-19 from Traditional Chinese Medicine (TCM) by using a data-driven approach. Ren X; Shao XX; Li XX; Jia XH; Song T; Zhou WY; Wang P; Li Y; Wang XL; Cui QH; Qiu PJ; Zhao YG; Li XB; Zhang FC; Li ZY; Zhong Y; Wang ZG; Fu XJ J Ethnopharmacol; 2020 Aug; 258():112932. PubMed ID: 32376368 [TBL] [Abstract][Full Text] [Related]
31. Network pharmacology, molecular docking, and dynamics analyses to predict the antiviral activity of ginger constituents against coronavirus infection. Samy A; Hassan A; Hegazi NM; Farid M; Elshafei M Sci Rep; 2024 May; 14(1):12059. PubMed ID: 38802394 [TBL] [Abstract][Full Text] [Related]
32. Uncovering the action mechanism of Shenqi Tiaoshen formula in the treatment of chronic obstructive pulmonary disease through network pharmacology, molecular docking, and experimental verification. Qinjun Y; Dandan Y; Hui W; Yating G; Xinheng W; Di WU; Jiabing T; Chuanbo W; Zegeng LI J Tradit Chin Med; 2024 Aug; 44(4):770-783. PubMed ID: 39066538 [TBL] [Abstract][Full Text] [Related]
33. Bioactive Components of Yuan H; Liu L; Zhou J; Zhang T; Daily JW; Park S J Med Food; 2022 Apr; 25(4):355-366. PubMed ID: 35438554 [TBL] [Abstract][Full Text] [Related]
34. Potential Targets and Mechanisms of Bitter Almond-Licorice for COVID-19 Treatment Based on Network Pharmacology and Molecular Docking. Hong Q; Shang X; Wu Y; Nie Z; He B Curr Pharm Des; 2023; 29(33):2655-2667. PubMed ID: 38018195 [TBL] [Abstract][Full Text] [Related]
35. Anti-coronavirus and anti-pulmonary inflammation effects of iridoids, the common component from Chinese herbal medicines for the treatment of COVID-19. Huang DY; Luo YX; Zheng WD; Wu SY; Huang PQ; Jin JW; Wu PP; Gan LS J Nat Med; 2024 Sep; 78(4):1003-1012. PubMed ID: 38775895 [TBL] [Abstract][Full Text] [Related]
36. Isolation and identification of the components in Cybister chinensis Motschulsky against inflammation and their mechanisms of action based on network pharmacology and molecular docking. Che YH; Xu ZR; Ni LL; Dong XX; Yang ZZ; Yang ZB J Ethnopharmacol; 2022 Mar; 285():114851. PubMed ID: 34808299 [TBL] [Abstract][Full Text] [Related]
37. Mechanism of Sanhua Decoction in the Treatment of Ischemic Stroke Based on Network Pharmacology Methods and Experimental Verification. YingHuang ; Gao SS; Gong ZH; Li WJ; Xiao-junGou ; Sun JJ; Sun MJ Biomed Res Int; 2022; 2022():7759402. PubMed ID: 35097126 [TBL] [Abstract][Full Text] [Related]
38. In Silico Screening of Potential Chinese Herbal Medicine Against COVID-19 by Targeting SARS-CoV-2 3CLpro and Angiotensin Converting Enzyme II Using Molecular Docking. Gao LQ; Xu J; Chen SD Chin J Integr Med; 2020 Jul; 26(7):527-532. PubMed ID: 32632717 [TBL] [Abstract][Full Text] [Related]
39. Exploring the Molecular Mechanism of Niuxi-Mugua Formula in Treating Coronavirus Disease 2019 Wang W; Cao X; Cao YN; Liu LL; Zhang SL; Qi WY; Zhang JX; Yang XZ; Li XK; Zao XB; Ye YA Curr Comput Aided Drug Des; 2024; 20(7):1113-1129. PubMed ID: 37855353 [TBL] [Abstract][Full Text] [Related]
40. Active components in Ephedra sinica stapf disrupt the interaction between ACE2 and SARS-CoV-2 RBD: Potent COVID-19 therapeutic agents. Mei J; Zhou Y; Yang X; Zhang F; Liu X; Yu B J Ethnopharmacol; 2021 Oct; 278():114303. PubMed ID: 34102269 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]